The Research and Development Scientists at Wugen focus on innovating and refining immuno-oncology cell therapies, specifically off-the-shelf NK and CAR-T therapies. This team conducts cutting-edge research, designs and executes experiments, and develops processes to enhance the efficacy and safety of treatments for solid tumors and hematologic malignancies. Their collaborative efforts ensure the advancement of Wugen's product pipeline from concept to clinical application.
Alexander Hamil
Senior Scientist
Barbara Muz
Senior Scientist
Brunda Tumala
Director CMC Process Developme...
Gregory Watson
Senior Scientist
Jimmy Pham
Senior Associate Scientist
John Dean
Senior Scientist
John Gierer
Senior Associate Scientist
Melissa Berkowitz
Principal Scientist - CMC MSAT
Rachel Langland
Director, Analytical Developme...
Tonya Brewer
Principal Scientist, Quality A...
View all